Table 3. Full names and structures for compounds listed by ligand ID in Table 2.
PDB Ligand ID | PDB ID | Reference | Ligand Name1 |
243 | 2VST | [46] | 13-hydroxyoctadecadienoic acid(13-HODE) |
570 | 1FM9 | [37] | GI262570(Farglitazar) |
4HD | 2VV1 | [46] | (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid(4-HDHA) |
9HO | 2VSR | [46] | 9-hydroxyoctadecadienoic acid(9-HODE) |
DRH | 2I4P | [45] | (2S)-2-[4-[2-(1,3-benzoxazol-2-yl-heptyl-amino)ethyl]phenoxy]-2-methyl-butanoic acid((2S)-ureidofibrate-like derivative) |
DRJ | 2I4J | [45] | (2R)-2-[4-[2-(1,3-benzoxazol-2-yl-heptyl-amino)ethyl]phenoxy]-2-methyl-butanoic acid((2R)-ureidofibrate-like derivative) |
DRY | 2HWQ | [44] | [(1-{3-[(6-benzoyl-1-propyl-2-naphthyl)oxy]propyl}-1H-indol-5-yl)oxy]acetic acid(5-substituted indoleoxyacetic acid analogue) |
EHA | 2F4B | [43] | (5-{3-[(6-benzoyl-1-propyl-2-naphthyl)oxy]propoxy}-1H-indol-1-yl)acetic acid(Indol-1-yl acetic acid) |
ET1 | 3ET3 | [47] | 3-[5-methoxy-1-(4-methoxyphenyl)sulfonyl-indol-3-yl] propanoic acid(indeglitazar) |
HXA | 2VV0 | [46] | Docosa-4,7,10,13,16,19-hexaenoic acid |
PTG | 2ZK12ZK2 | [48] | 15-deoxy-delta(12,14)-prostaglandin J2 (PTG) |
Ligand IDs from respective PDB files were used. Ligand structures can be found in Table S1.
Abbreviations for ligands mentioned in the text are in parentheses following the full name of the compound.